Cost Increases For Branded Drugs Outpace Inflation

Reuters: U.S. Price Hikes On Branded Drugs Far Outpace 2012 Inflation
U.S. price increases on popular branded drugs in the past year have been more than six times the overall rate of inflation for consumer goods, while spending on specialty medications is up nearly 23 percent, according to data compiled by Express Scripts for its first quarterly drug trend report (Berkrot, 11/28).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.